zepbound wegovy weight loss - Search News

News

CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy

Associated Press News on MSN · 1h

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Zepbound tops Wegovy for weight loss in first head-to-head study comparing the drugs

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

Zepbound vs. Wegovy: Here's which weight loss drug worked best in first trial

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what researchers found.

1hon MSN

Popular injected weight loss medications work better for one sex. Researchers want to know why

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

4d

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

3d

Is Zepbound or Wegovy better for weight loss? First-of-its-kind study offers answer

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Technology Networks15h

Zepbound Outcompetes Wegovy for Weight Loss in Head-to-Head Trials

Tirzepatide promoted greater weight loss in individuals with obesity than semaglutide in a clinical trial that compared the ...

Everyday Health on MSN1d

Zepbound Beats Wegovy for Weight Loss in First Head-to-Head Trial

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results